Business
ChromaDex Launches New Line of High Purity Cannabinoid (CBD) Reference Standards Available for Research and Analytical Testing Worldwide
ChromaDex launches new research tools for the CBD industry with line of reference standards LOS ANGELES, Feb. 03, 2020 (GLOBE NEWSWIRE) -- ChromaDex Corp.
About this update from Niagen Bioscience, Inc.
[{"type":"text","content":"ChromaDex launches new research tools for the CBD industry with line of reference standards\nLOS ANGELES, Feb. 03, 2020 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced the expansion of its industry-leading reference standards business with a new line of cannabinoid (CBD) reference standards available to researchers across the globe. These new materials are for laboratory use only, not for human consumption.\n “In the CBD space, we see an abundance of misinformation and a dearth of quality standards testing,” says Rob Fried, ChromaDex CEO and member of the Board of Directors of the Council for Responsible Nutrition. “ChromaDex has been a leader in standards testing for over 20 years, and we look forward to helping bring some scientific integrity to those interested in CBD.” Reference standards are used as benchmarks or markers to confirm the identity and potency of products. ChromaDex is the leading provider of phytochemical reference standards, botanical reference materials, and research grade materials for the natural products industry with over 1750 phytochemicals and 400 botanical reference materials in its catalog. The Company welcomes two cannabinoid reference standards, Cannabidiol (CBD) and Cannabidivarin (CBD-V), derived from hemp for laboratory use in the identification and qualification of hemp and CBD ingredients or products. “We support the establishment of a safe limit of CBD for consumers,” notes ChromaDex Co-Founder & Executive Chairman Frank Jaksch. “Our tools will help researchers and companies develop quality products that match label claims.” For additional information on reference standards, please visit standards.chromadex.com. About ChromaDex:ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN® nicotinamide riboside chloride, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well a...